BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Penumbra, Inc. Reports Second Quarter 2022 Financial Results

  Penumbra, Inc., a global healthcare company focused on innovative therapies, reported financial results for the second quarter ended June 30, 2022.

  August 4, 2022

   · 

  8 min read
• Business

  Theravance Biopharma, Inc. Reports Second Quarter 2022 Financial Results and Provides Business Update

  Theravance Biopharma, Inc. (“Theravance Biopharma” or the “Company”) (NASDAQ: TBPH) today reported financial results for the second quarter of 2022.

  August 4, 2022

   · 

  15 min read
• Business

  Lyell Immunopharma Reports Second Quarter 2022 Financial Results and Business Highlights

  Lyell Immunopharma, Inc., a clinical‑stage T-cell reprogramming company dedicated to developing curative cell therapies for patients with solid tumors, provided business highlights and reported financial results for the second quarter of 2022.

  August 4, 2022

   · 

  11 min read
• Business

  Onconova Therapeutics to Provide Corporate Update and Announce Second Quarter Financial Results on August 11, 2022

  Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, announced that the Company intends to release its second quarter 2022 financial results on Thursday, August 11, 2022.

  August 4, 2022

   · 

  1 min read
• Business

  Collegium Reports Second Quarter 2022 Financial Results

  Collegium Pharmaceutical, Inc., a leading, diversified specialty pharmaceutical company, reported its financial results for the quarter ended June 30, 2022 and provided a corporate update.

  August 4, 2022

   · 

  15 min read
• Business

  Iovance Biotherapeutics Reports Second Quarter and First Half 2022 Financial Results and Corporate Updates

  Iovance Biotherapeutics, Inc., a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, reported second quarter and first half 2022 financial results and corporate updates.

  August 4, 2022

   · 

  13 min read
• Business

  Voyager Therapeutics Prioritizes Pipeline and Reports Second Quarter 2022 Financial and Operating Results

  Voyager Therapeutics, Inc., a gene therapy and neuroscience company developing life-changing treatments and next-generation adeno-associated virus capsids, unveiled its prioritized therapeutic pipeline and reported second quarter 2022 financial and operating results.

  August 4, 2022

   · 

  18 min read
• Business

  Codexis Reports Second Quarter 2022 Financial Results

  Codexis, Inc., a leading enzyme engineering company enabling the promise of synthetic biology, announced financial results for the second quarter ended June 30, 2022 and provided a business update.

  August 4, 2022

   · 

  15 min read
• BioCapital

  Kala Pharmaceuticals to Participate in Upcoming Investor Conferences in August 2022

  Kala Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for rare diseases of the eye, announced that management will participate in the following virtual healthcare investor conferences in August 2022:

  August 4, 2022

   · 

  1 min read
• Business

  Coherus BioSciences Reports Second Quarter 2022 Results and Provides Business Update

  Coherus BioSciences, Inc., reported financial results for the quarter ended June 30, 2022 and recent business highlights.

  August 4, 2022

   · 

  15 min read